An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease

Archives of Internal Medicine

Volumn 160, Issue 20, 2000, Pages 3123-3127

  Hebert, Patricia R ^a,c   Hennekens, Charles H ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MORTALITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE; TREATMENT OUTCOME;

EID: 0034645456     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.20.3123     Document Type: Article

References (12)

1. Internal analgesic, antipyretic, and antirheumatic drug products for over-thecounter human use: Final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products
2. Final report on the aspirin component of the ongoing Physicians' Health Study
3. Randomized trial of prophylactic daily aspirin in British male doctors
4. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease
5. Proceedings of the American College of Chest Physicians 5th Consensus on Antithrombotic Therapy
6. Aspirin as a therapeutic agent in cardiovascular disease: A statement for healthcare professionals from the American Heart Association
7. Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
8. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial
9. Aspirin and risk of hemorrhagic stroke: A metaanalysis of randomized controlled trials
10. Collaborative overview of randomized trials of antiplatelet therapy, 1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patient
11. The Women's Health Study: Summary of the study design